Physician profile
Mark Beaty
NPI 1225118326
$10,598.44
in general payments reported to CMS, 2019-2025
5 companies · $443 in 2025
The $443 reported for 2025 was more than what 77% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $556 · 2020: $96.73 · 2021: $3,530 · 2022: $1,033 · 2023: $3,923 · 2024: $1,016 · 2025: $443.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,584 · Food and Beverage: $1,393 · Long Term Medical Supply Or Device Loan: $405.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,584.17 |
| Food and Beverage | $1,392.58 |
| Long Term Medical Supply Or Device Loan | $404.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $4,450.98 | 2023-2025 | Botox |
| Allergan, INC. | $3,865.47 | 2019-2022 | |
| Merz North America, INC. | $1,557.37 | 2019-2023 | |
| Integra Lifesciences Corporation | $404.85 | 2024 | Acell |
| Revance Therapeutics, INC. | $319.77 | 2024-2025 | Daxxify |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Beaty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.